It is absolutely the case that Gregory Bolan’s experience as a research analyst is very strong. There is a reason he is currently a Senior Research Analyst covering Healthcare IT and Pharmaceutical Services with Nashville boutique investment firm Avondale Partners, LLC. As an investment management firm, Avondale keeps their eye on the future of healthcare stocks and Greg helps.
Prior to his current role at Avondale Partners, Greg served as the Managing Director of Healthcare Equity Research with the Nashville office of Sterne Agee, where he focused primarily on pharmaceutical companies. He has been lauded for his success, having been named one of the “Best Up & Comers” as part of Institutional Investor's All-American Research Team Survey in 2010. Then, in 2014, Greg Bolan was recognized as a Nunber One Stock Picker for Life Science Tools & Services by Starmine.
While he was at Sterne Agee, Gregory Boland also played a crucial role when it came to building an extremely skilled and knowledgeable team of healthcare analysts to examine such sub-sectors as Specialty Pharma, Managed Care and Medical Devices & Diagnostics. So far, Greg’s financial services career has been focused on the healthcare and targeted middle market sectors.
Greg Bolan also spent a lot of time as a Director of Healthcare Equity Research for Wells Fargo Securities and he has also been a Senior Associate of Healthcare Equity Research with Jefferies & Company. Almost all of his work has been in Nashville, although he was also an Associate with a focus in healthcare at FNY GMG Capital in New York City, as well.